The Weight Loss Price Wars Have Begun Amazon's move to offer popular weight loss drugs for $50 a month to eligible Medicare patients has disrupted the long standing debate over healthcare costs.
Pharmaceutical companies have dictated exorbitant prices for life saving medications, leaving millions without access. The introduction of the Medicare GLP 1 Bridge Program has finally altered this status quo.
By partnering with Eli Lilly to offer Wegovy, Zepbound KwikPen, and Foundayo at a significantly reduced price point, Amazon is attempting to upend the traditional pharmacy model.